Endotracheal Intubation Among the Critically Ill: HEMAIR Pilot Study (HEMAIR)

January 28, 2020 updated by: Nathan J. Smischney, Mayo Clinic

Current State of Endotracheal Intubation Among the Critically Ill and Exploring Risk Factors for Immediate Complications of Endotracheal Intubation: a Prospective, Observational Multi-center Study (HEMAIR)

In order to examine the current endotracheal intubation practice among critically ill patients, a prospective observational multicenter study of adult critically ill patients was conducted from July 2015 to January 2017 involving 20 ICUs. In this study, the primary aim was to describe, through a prospective observational multicenter study, the current intubation practice of adult critically ill patients undergoing endotracheal intubations with a focus on deriving and validating a prediction model for both immediate airway and hemodynamic complications.

Study Overview

Status

Completed

Conditions

Detailed Description

Aim 1: To derive and validate a prediction model for difficult airway (three or more attempts at laryngoscopy to place an endotracheal tube and/or the need for another operator among the critically ill) [37].

Aim 2: To derive and validate a prediction model for hemodynamic compromise, i.e., post-intubation hypotension [defined as a decrease at any point in mean arterial pressure less than 65 mmHg; systolic blood pressure less than 80 mm Hg and/or a reduction in systolic blood pressure of 40% from baseline; or the initiation of, or increase in infusion dosage of, any vasopressor medication (bolus or infusion) during the 30 minute period following intubation] [38-39].

Aim3: To derive and validate a predication model for hypoxemia (decrease in pulse oximetry to oxygen saturation less than 88% during the procedure).

Study Type

Observational

Enrollment (Actual)

1288

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Scottsdale, Arizona, United States, 85054
        • Mayo Clinic, Scottsdale
    • California
      • Los Angeles, California, United States, 90089
        • University of South California
      • Modesto, California, United States, 95355
        • Memorial Medical Center
    • Connecticut
      • Bridgeport, Connecticut, United States, 06610
        • Bridgeport Hospital/Yale
    • Florida
      • Jacksonville, Florida, United States, 32224
        • Mayo Clinic, Jacksonville
    • Kentucky
      • Lexington, Kentucky, United States, 40506
        • University Of Kentucky
    • Massachusetts
      • Pittsfield, Massachusetts, United States, 01201
        • Cynthia Callahan,Berkshire Medical Center
    • Michigan
      • Detroit, Michigan, United States, 48201
        • Detroit Medical Center
    • Missouri
      • Saint Louis, Missouri, United States, 63141
        • Mercy Hospital
    • Nebraska
      • Omaha, Nebraska, United States, 68729
        • Creighton University
    • Ohio
      • Cleveland, Ohio, United States, 44195
        • Cleveland Clinic
    • Oklahoma
      • Oklahoma City, Oklahoma, United States, 73104
        • University of Oklahoma Health Sciences Center
    • Pennsylvania
      • Danville, Pennsylvania, United States, 17822
        • Geisinger Health System
    • Texas
      • Corpus Christi, Texas, United States, 78412
        • Corpus Christi Medical Center
    • Wisconsin
      • Marshfield, Wisconsin, United States, 54729
        • Marshfield Clinic
      • Milwaukee, Wisconsin, United States, 53204
        • Arora Health Care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adult patients admitted to 20 participating medical/surgical/mixed ICUs who underwent endotracheal intubation.

Description

Inclusion Criteria:

  • Patient age ≥ 18 years
  • Surgical and medical intensive care unit adult patients
  • Adult patients requiring endotracheal intubation during the time period of study

Exclusion Criteria:

  • Patient age < 18 years
  • Endotracheal intubations performed outside the ICU (in the operating room, in and outside the hospital) are excluded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with Hypoxemia in the 30 minutes following intubation
Time Frame: 30 minutes
30 minutes
Number of participants with hypotension in the 30 minutes following intubation
Time Frame: 30 minutes
30 minutes
Number of participants with unanticipated difficult airway
Time Frame: 10 minutes
defined by 3 or more attempts or two operators
10 minutes

Secondary Outcome Measures

Outcome Measure
Time Frame
Mechanical ventilation free days in-hospital
Time Frame: 28 days or in-hospital
28 days or in-hospital
Total days of ICU/hospital length of stay
Time Frame: 30 days or in-hospital
30 days or in-hospital
Number of participants with vital status (dead/alive)
Time Frame: 30 days or in-hospital
30 days or in-hospital
Number of participants with disposition to home, nursing home or long term care facility
Time Frame: 30 days or in-hospital
30 days or in-hospital

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2015

Primary Completion (Actual)

December 1, 2017

Study Completion (Actual)

December 1, 2019

Study Registration Dates

First Submitted

July 21, 2015

First Submitted That Met QC Criteria

July 23, 2015

First Posted (Estimate)

July 27, 2015

Study Record Updates

Last Update Posted (Actual)

January 30, 2020

Last Update Submitted That Met QC Criteria

January 28, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tracheal Intubation

Subscribe